Roche Holding AG entered into a definitive merger agreement to acquire Carmot Therapeutics Inc. frim shareholders for approximately $3.1 billion.
Roche Holding AG entered into a definitive merger agreement to acquire Carmot Therapeutics Inc. frim shareholders for approximately $3.1 billion on December 4, 2023. Under the terms of the agreement,...